MAA
KITE

Managed Account Advisors’s Kite Pharma, Inc. KITE Stock Holding History

Managed Account Advisors’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		$15K Buy
+246
New +$14K ﹤0.01% 2845
2015
Q1 		– Sell
-42
Closed -$2K – 3107
2014
Q4 		$2K Buy
+42
New +$1.77K ﹤0.01% 2695

Other funds holding KITE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WCM
Wildcat Capital Management New York $106M AUM 0.1% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Managed Account Advisors's KITE Position: Q2 2015 in Review

Managed Account Advisors opened a new position in Kite Pharma, Inc. (KITE) in Q2 2015: 246 shares worth $15K. The stake represents ﹤0.01% of the portfolio and ranks #2845 among its holdings. This is a return to the name: Managed Account Advisors previously reported a position in KITE as recently as Q4 2014.

Managed Account Advisors first reported a position in KITE in Q4 2014 and has held it in 2 quarters since. 155 funds tracked by Wall St. Rank hold KITE as of Q2 2015.

  • Managed Account Advisors held 246 shares of Kite Pharma, Inc. worth $15K as of Q2 2015.
  • Kite Pharma, Inc. was a new Managed Account Advisors position in Q2 2015.
  • Kite Pharma, Inc. made up ﹤0.01% of Managed Account Advisors's portfolio in Q2 2015, its #2845 holding.
  • Managed Account Advisors first reported a position in Kite Pharma, Inc. in Q4 2014 and has held it in 2 quarters since.
  • 155 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q2 2015.

Based on Managed Account Advisors's 13F filing for Q2 2015, filed 14 Aug 2015.